Group 13 HOX proteins interact with the MH2 domain of R-Smads and modulate Smad transcriptional activation functions independent of HOX DNA-binding capability

Nucleic Acids Research

Volumn 33, Issue 14, 2005, Pages 4475-4484

  Williams, Thomas M ^a   Williams, Melissa E ^a   Heaton, Joanne H ^a   Gelehrter, Thomas D ^a   Innis, Jeffrey W ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; BONE MORPHOGENETIC PROTEIN; HOX PROTEIN; HYBRID PROTEIN; PROTEIN HOX13; SMAD PROTEIN; SMAD1 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD5 PROTEIN; TRANSCRIPTION FACTOR GAL4; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; HOMEOBOX PROTEIN HOXA13; HOMEODOMAIN PROTEIN; HOXD13 PROTEIN, HUMAN; HOXD13 PROTEIN, MOUSE; PHOSPHOPROTEIN; SMAD1 PROTEIN, HUMAN; SMAD1 PROTEIN, MOUSE; SMAD3 PROTEIN, HUMAN; SMAD3 PROTEIN, MOUSE; SMAD5 PROTEIN, HUMAN; SMAD5 PROTEIN, MOUSE; TGFB1 PROTEIN, HUMAN; TGFB1 PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CULTURE; CONTROLLED STUDY; DELETION MUTANT; EMBRYO; ENZYME ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; SCREENING TEST; SIGNAL TRANSDUCTION; TWO HYBRID SYSTEM; YEAST; ANIMAL; C57BL MOUSE; CELL LINE; CHEMISTRY; DRUG ANTAGONISM; GENE LIBRARY; LIMB; METABOLISM; PHYSIOLOGY; PRENATAL DEVELOPMENT; PROTEIN TERTIARY STRUCTURE; TRANSACTIVATION;

MAMMALIA;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL LINE; DNA-BINDING PROTEINS; EXTREMITIES; GENE LIBRARY; HOMEODOMAIN PROTEINS; HUMANS; MICE; MICE, INBRED C57BL; PHOSPHOPROTEINS; PROTEIN STRUCTURE, TERTIARY; SMAD PROTEINS; SMAD1 PROTEIN; SMAD3 PROTEIN; SMAD5 PROTEIN; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 23344431857     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gki761     Document Type: Article

References (77)

1. Krumlauf,R. (1994) Hox genes in vertebrate development. Cell, 78, 191-201.
2. Innis,J.W., Goodman,F.R., Bacchelli,C., Williams,T.M., Mortlock,D.P., Sateesh,P., Scambler,P.J., McKinnon,W. and Guttmacher,A.E. (2002) A HOXA13 allele with a missense mutation in the homeobox and a dinucleotide deletion in the promoter underlies Guttmacher syndrome. Hum. Mutat., 19, 573-574.
3. Innis,J.W., Mortlock,D., Chen,Z., Ludwig,M., Williams,M.E., Williams,T.M., Doyle,C.D., Shao,Z., Glynn,M., Mikulic,D. et al. (2004) Polyalanine expansion in HOXA13: Three new affected families and the molecular consequences in a mouse model. Hum. Mol. Genet., 13, 2841-2851.
4. Mortlock,D.P. and Innis,J.W. (1997) Mutation of HOXA13 in hand-foot-genital syndrome. Nature Genet., 15, 179-180.
5. Goodman,F.R., Bacchelli,C., Brady,A.F., Brueton,L.A., Fryns,J.P., Mortlock,D.P., Innis,J.W., Holmes,L.B., Donnenfeld,A.E., Feingold,M. et al. (2000) Novel HOXA13 mutations and the phenotypic spectrum of hand-foot-genital syndrome. Am. J. Hum. Genet., 67, 197-202.
6. Fromental-Ramain,C., Warot,X., Lakkaraju,S., Favier,B., Haack,H., Birling,C., Dierich,A., Dolle,P. and Chambon,P. (1996) Specific and redundant functions of the paralogous Hoxa-9 and Hoxd-9 genes in forelimb and axial skeleton patterning. Development, 122, 461-472.
7. Fromental-Ramain,C., Warot,X., Messadecq,N., LeMeur,M., Dolle,P. and Chambon,P. (1996) Hoxa-13 and Hoxd-13 play a crucial role in the patterning of the limb autopod. Development, 122, 2997-3011.
8. Mortlock,D.P., Post,L.C. and Innis,J.W. (1996) The molecular basis of Hypodactyly (Hd): A deletion in Hoxa13 leads to arrest of digital arch formation. Nature Genet., 13, 284-289.
9. Post,L.C. and Innis,J.W. (1999) Infertility in adult Hypodactyly mice is associated with hypoplasia of distal reproductive structures. Biol. Reprod., 61, 1402-1408.
10. Post,L.C. and Innis,J.W. (1999) Altered Hox expression and increased cell death distinguish Hypodactyly from Hoxa13 null mice. Int. J. Dev. Biol., 43, 287-294.
11. Post,L.C., Margulies,E.H., Kuo,A. and Innis,J.W. (2000) Severe limb defects in Hypodactyly mice result from the expression of a novel, mutant HOXA13 protein. Dev. Biol., 217, 290-300.
12. Stadler,H.S., Higgins,K.M. and Capecchi,M.R. (2001) Loss of Eph-receptor expression correlates with loss of cell adhesion and chondrogenic capacity in Hoxa13 mutant limbs. Development, 128, 4177-4188.
13. Morgan,E.A., Nguyen,S.B., Scott,V. and Stadler,H.S. (2003) Loss of Bmp7 and Fgf8 signaling in Hoxa13-mutant mice causes hypospadia. Development, 130, 3095-3109.
14. Goodman,F.R. (2002) Limb malformations and the human HOX genes. Am. J. Med. Genet., 112, 256-265.
15. Warot,X., Fromental-Ramain,C., Fraulob,V., Chambon,P. and Dolle,P. (1997) Gene dosage-dependent effects of the Hoxa-13 and Hoxd-13 mutations on morphogenesis of the terminal parts of the digestive and urogenital tracts. Development, 124, 4781-4791.
16. Mann,R.S. and Affolter,M. (1998) Hox proteins meet more partners. Curr. Opin. Genet. Dev., 8, 423-429.
17. Chang,C.P., Shen,W.F., Rozenfeld,S., Lawrence,H.J., Largman,C. and Cleary,M.L. (1995) Pbx proteins display hexapeptide-dependent cooperative DNA binding with a subset of Hox proteins. Genes Dev., 9, 663-674.
18. Chang,C.P., Brocchieri,L., Shen,W.F., Largman,C. and Cleary,M.L. (1996) Pbx modulation of Hox homeodomain amino-terminal arms establishes different DNA-binding specificities across the Hox locus. Mol. Cell. Biol., 16, 1734-1745.
19. Shen,W.F., Montgomery,J.C., Rozenfeld,S., Moskow,J.J., Lawrence,H.J., Buchberg,A.M. and Largman,C. (1997) AbdB-like Hox proteins stabilize DNA binding by the Meis1 homeodomain proteins. Mol. Cell. Biol., 17 6448-6458.
20. Williams,T.M., Williams,M.E. and Innis,J.W. (2005) Range of HOX/TALE superclass associations and protein domain requirements for HOXA13:MEIS interaction. Dev. Biol., 277, 457-471.
21. Mercader,N., Leonardo,E., Azpiazu,N., Serrano,A., Morata,G., Martinez,C. and Torres,M. (1999) Conserved regulation of proximodistal limb axis development by Meis1/Hth. Nature, 402, 425-429.
22. Mercader,N., Leonardo,E., Piedra,M.E., Martinez,A.C., Ros,M.A. and Torres,M. (2000) Opposing RA and FGF signals control proximodistal vertebrate limb development through regulation of Meis genes. Development, 127, 3961-3970.
23. Moustakas,A., Souchelnytskyi,S. and Heldin,C.H. (2001) Smad regulation in TGF-beta signal transduction. J. Cell. Sci., 114, 4359-4369.
24. Shi,Y. and Massague,J. (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell, 113, 685-700.
25. Chang,H., Huylebroeck,D., Verschueren,K., Guo,Q., Matzuk,M.M. and Zwijsen,A. (1999) Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects. Development, 126 1631-1642.
26. Yang,X., Castilla,L.H., Xu,X., Li,C., Gotay,J., Weinstein,M., Liu,P.P. and Deng,C.X. (1999) Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5. Development, 126, 1571-1580.
27. Wanek,N., Muneoka,K., Holler-Dinsmore,G., Burton,R. and Bryant,S.V. (1989) A staging system for mouse limb development. J. Exp. Zool., 249, 41-49.
28. Finley,R.L.,Jr and Brent,R. (1994) Interaction mating reveals binary and ternary connections between Drosophila cell cycle regulators. Proc. Natl Acad. Sci. USA, 91, 12980-12984.
29. Kolonin,M.G., Zhong,J. and Finley,R.L. (2000) Interaction mating methods in two-hybrid systems. Methods Enzymol., 328, 26-46.
30. Altschul,S.F., Gish,W., Miller,W., Myers,E.W. and Lipman,D.J. (1990) Basic local alignment search tool. J. Mol. Biol., 215, 403-410.
31. Thompson,J.D., Higgins,D.G. and Gibson,T.J. (1994) CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res., 22, 4673-4680.
32. Simeone,D.M., Pham,T. and Logsdon,C.D. (2000) Disruption of TGFbeta signaling pathways in human pancreatic cancer cells. Ann. Surg., 232, 73-80.
33. Song,C.Z., Tian,X. and Gelehrter,T.D. (1999) Glucocorticoid receptor inhibits transforming growth factor-beta signaling by directly targeting the transcriptional activation function of Smad3. Proc. Natl Acad. Sci. USA, 96, 11776-11781.
34. Song,C.Z., Siok,T.E. and Gelehrter,T.D. (1998) Smad4/DPC4 and Smad3 mediate transforming growth factor-beta (TGF-beta) signaling through direct binding to a novel TGF-beta-responsive element in the human plasminogen activator inhibitor-1 promoter. J. Biol. Chem., 273 29287-29290.
35. Keeton,M.R., Curriden,S.A., van Zonneveld,A.J. and Loskutoff,D.J. (1991) Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor beta. J. Biol. Chem., 266, 23048-23052.
36. Heaton,J.H., Dlakic,W.M., Dlakic,M. and Gelehrter,T.D. (2001) Identification and cDNA cloning of a novel RNA-binding protein that interacts with the cyclic nucleotide-responsive sequence in the Type-1 plasminogen activator inhibitor mRNA. J. Biol. Chem., 276, 3341-3347.
37. Zhang,Y., Feng,X., We,R. and Derynck,R. (1996) Receptor-associated Madhomologues synergize as effectors of the TGF-beta response. Nature 383, 168-172.
38. Zhang,Y., Feng,X.H. and Derynck,R. (1998) Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription. Nature, 394, 909-913.
39. Yingling,J.M., Datto,M.B., Wong,C., Frederick,J.P., Liberati,N.T. and Wang,X.F. (1997) Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein. Mol. Cell. Biol., 17, 7019-7028.
40. Yang,X., Ji,X., Shi,X. and Cao,X. (2000) Smad1 domains interacting with Hoxc-8 induce osteoblast differentiation. J. Biol. Chem., 275 1065-1072.
41. Shi,X., Yang,X., Chen,D., Chang,Z. and Cao,X. (1999) Smad1 interacts with homeobox DNA-binding proteins in bone morphogenetic protein signaling. J. Biol. Chem., 274, 13711-13717.
42. Derynck,R. and Zhang,Y.E. (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signaling. Nature, 425, 577-584.
43. Wrana,J.L., Attisano,L., Carcamo,J., Zentella,A., Doody,J., Laiho,M., Wang,X.F. and Massague,J. (1992) TGF beta signals through a heteromeric protein kinase receptor complex. Cell, 71, 1003-1014.
44. Lagna,G., Hata,A., Hemmati-Brivanlou,A. and Massague,J. (1996) Partnership between DPC4 and SMAD proteins in TGF-beta signaling pathways. Nature, 383, 832-836.
45. Xu,W., Angelis,K., Danielpour,D., Haddad,M.M., Bischof,O., Campisi,J., Stavnezer,E. and Medrano,E.E. (2000) Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor. Proc. Natl Acad. Sci. USA, 97, 5924-5929.
46. Caronia,G., Goodman,F.R., McKeown,C.M., Scambler,P.J. and Zappavigna,V. (2003) An I47L substitution in the HOXD13 homeodomain causes a novel human limb malformation by producing a selective loss of function. Development, 130, 1701-1712.
47. Williams,T.M., Williams,M.E., Kuick,R., Misek,D., McDonagh,K., Hanash,S. and Innis,J.W. (2005) Candidate downstream regulated genes of HOX group 13 transcription factors with and without monomeric DNA binding capability. Dev. Biol., 279, 462-480.
48. Shi,X., Bai,S., Li,L. and Cao,X. (2001) Hoxa-9 represses transforming growth factor-beta-induced osteopontin gene transcription. J. Biol. Chem., 276, 850-855.
49. Hata,A., Lo,R.S., Wotton,D., Lagna,G. and Massague,J. (1997) Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4. Nature, 388, 82-87.
50. Shen,W.F., Krishnan,K., Lawrence,H.J. and Largman,C. (2001) The HOX homeodomain proteins block CBP histone acetyltransferase activity. Mol. Cell. Biol., 21, 7509-7522.
51. Shen,W.F., Chang,C.P., Rozenfeld,S., Sauvageau,G., Humphries,R.K., Lu,M., Lawrence,H.J., Cleary,M.L. and Largman,C. (1996) Hox homeodomain proteins exhibit selective complex stabilities with Pbx and DNA. Nucleic Acids Res., 24, 898-906.
52. Shen,W.F., Rozenfeld,S., Lawrence,H.J. and Largman,C. (1997) The Abd-B-like Hox homeodomain proteins can be subdivided by the ability to form complexes with Pbx1a on a novel DNA target. J. Biol. Chem., 272, 8198-8206.
53. Grienenberger,A., Merabet,S., Manak,J., Iltis,I., Fabre,A., Berenger,H., Scott,M.P., Pradel,J. and Graba,Y. (2003) Tgfbeta signaling acts on a Hox response element to confer specificity and diversity to Hox protein function. Development, 130, 5445-5455.
54. Wan,M., Shi,X., Feng,X. and Cao,X. (2001) Transcriptional mechanisms of bone morphogenetic protein-induced osteoprotegrin gene expression. J. Biol. Chem., 276, 10119-10125.
55. Yang-Yen,H.F., Chambard,J.C., Sun,Y.L., Smeal,T., Schmidt,T.J., Drouin,J. and Karin,M. (1990) Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction. Cell, 62, 1205-1215.
56. Ray,A. and Prefontaine,K.E. (1994) Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc. Natl Acad. Sci. USA, 91 752-756.
57. Scheinman,R.I., Gualberto,A., Jewell,C.M., Cidlowski,J.A. and Baldwin,A.S.,Jr (1995) Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol. Cell. Biol., 15, 943-953.
58. Philips,A., Maira,M., Mullick,A., Chamberland,M., Lesage,S., Hugo,P. and Drouin,J. (1997) Antagonism between Nur77 and glucocorticoid receptor for control of transcription. Mol. Cell. Biol., 17, 5952-5959.
59. Pulichino,A.M., Vallette-Kasic,S., Couture,C., Gauthier,Y., Brue,T., David,M., Malpuech,G., Deal,C., Van Vliet,G., De Vroede,M. et al. (2003) Human and mouse TPIT gene mutations cause early onset pituitary ACTH deficiency. Genes Dev., 17, 711-716.
60. Island,M.L., Mesplede,T., Darracq,N., Bandu,M.T., Christeff,N., Djian,P., Drouin,J. and Navarro,S. (2002) Repression by homeoprotein Pitx1 of virus-induced interferon a promoters is mediated by physical interaction and trans repression of IRF3 and IRF7. Mol. Cell. Biol. 22, 7120-7133.
61. Dasen,J.S., O'Connell,S.M., Flynn,S.E., Treier,M., Gleiberman,A.S., Szeto,D.P., Hooshmand,F., Aggarwal,A.K. and Rosenfeld,M.G. (1999) Reciprocal interactions of Pit1 and GATA2 mediate signaling gradient-induced determination of pituitary cell types. Cell, 97, 587-598.
62. Pizette,S., Abate-Shen,C. and Niswander,L. (2001) BMP controls proximodistal outgrowth, via induction of the apical ectodermal ridge, and dorsoventral patterning in the vertebrate limb. Development, 128, 4463-4474.
63. Pizette,S. and Niswander,L. (2000)BMPs are required at two steps of limb chondrogenesis: Formation of prechondrogenic condensations and their differentiation into chondrocytes. Dev. Biol., 219, 237-249.
64. Yi,S.E., Daluiski,A., Pederson,R., Rosen,V. and Lyons,K.M. (2000) The type IBMP receptor BMPRIB is required for chondrogenesis in the mouse limb. Development, 127, 621-630.
65. Zou,H. and Niswander,L. (1996) Requirement for BMP signaling in interdigital apoptosis and scale formation. Science, 272, 738-741.
66. Knosp,W.M., Scott,V., Bachinger,H.P. and Stadler,H.S. (2004) HOXA13 regulates the expression of bone morphogenetic proteins 2 and 7 to control distal limb morphogenesis. Development, 131, 4581-4592.
67. Dahn,R.D. and Fallon,J.F. (2000) Interdigital regulation of digit identity and homeotic transformation by modulated BMP signaling. Science, 289, 438-441.
68. Guha,U., Gomes,W.A., Kobayashi,T., Pestell,R.G. and Kessler,J.A. (2002) In vivo evidence that BMP signaling is necessary for apoptosis in the mouse limb. Dev. Biol., 249, 108-120.
69. Pizette,S. and Niswander,L. (1999) BMPs negatively regulate structure and function of the limb apical ectodermal ridge. Development, 126, 883-894.
70. Yamamoto,M., Gotoh,Y., Tamura,K., Tanaka,M., Kawakami,A., Ide,H. and Kuroiwa,A. (1998) Coordinated expression of Hoxa-11 and Hoxa-13 during limb muscle patterning. Development, 125, 1325-1335.
71. Podlasek,C.A., Clemens,J.Q. and Bushman,W. (1999) Hoxa-13 gene mutation results in abnormal seminal vesicle and prostate development. J. Urol., 161, 1655-1661.
72. Zwijsen,A., van Grunsven,L.A., Bosman,E.A., Collart,C., Nelles,L., Umans,L., Van de Putte,T., Wuytens,G., Huylebroeck,D. and Verschueren,K. (2001) Transforming growth factor beta signalling in vitro and in vivo: activin ligand-receptor interaction, Smad5 in vasculogenesis, and repression of target genes by the deltaEF1/ ZEB-related SIP1 in the vertebrate embryo. Mol. Cell Endocrinol., 180, 13-24.
73. Goumans,M.J., Zwijsen,A., van Rooijen,M.A., Huylebroeck,D., Roelen,B.A. and Mummery,C.L. (1999) Transforming growth factor-beta signalling in extraembryonic mesoderm is required for yolk sac vasculogenesis in mice. Development, 126, 3473-3483.
74. Weinstein,M., Yang,X. and Deng,C. (2000) Functions of mammalian Smad genes as revealed by targeted gene disruption in mice. Cytokine Growth Factor Rev., 11, 49-58.
75. Dickson,M.C., Martin,J.S., Cousins,F.M., Kulkarni,A.B., Karlsson,S. and Akhurst,R.J. (1995) Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development, 121, 1845-1854.
76. Chen,Y., Knezevic,V., Ervin,V., Hutson,R., Ward,Y. and Mackem,S. (2004) Direct interaction with Hoxd proteins reverses Gli3-repressor function to promote digit formation downstream of Shh. Development, 131 2339-2347.
77. Liu,F., Massague,J. and Ruiz i Altaba,A. (1998) Carboxy-terminally truncated Gli3 proteins associate with Smads. Nature Genet., 20 325-326.